APO Research
Talk to an analyst

APO RESEARCH · REPORT

Dermatological Medicine

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Dermatological Medicine Market Analysis and Forecast 2026-2032

2 January 2026208 pages

Choose your research edition.

Industry ResearchDermatological Medicine Industry Research Report 2026138 pages · $2,950 USDIndustry Growth & TrendsGlobal Dermatological Medicine Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Dermatological Medicine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Dermatological Medicine Market Outlook and Growth Opportunities 2026207 pages · $4,250 USDMarket Analysis & ForecastGlobal Dermatological Medicine Market Analysis and Forecast 2026-2032208 pages · $4,950 USD

Market perspective

The global Dermatological Medicine market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Dermatological Medicine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Dermatological Medicine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Dermatological Medicine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Dermatological Medicine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Dermatological Medicine include Chongqing Huapont Pharm Co., China National Pharmaceutical Group, Xiuzheng Pharmaceutical Group, Johnson and Johnson, Merck, Harbin Letai, Pfizer, China Resources Pharmaceutical Group and Hebei Xinglong Xili Pharmaceutical, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Dermatological Medicine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Dermatological Medicine, also provides the sales of main regions and countries. Of the upcoming market potential for Dermatological Medicine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Dermatological Medicine sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Dermatological Medicine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Dermatological Medicine sales, projected growth trends, production technology, application and end-user industry.

Dermatological Medicine Segment by Company

Chongqing Huapont Pharm Co.

China National Pharmaceutical Group

Xiuzheng Pharmaceutical Group

Johnson and Johnson

Merck

Harbin Letai

Pfizer

China Resources Pharmaceutical Group

Hebei Xinglong Xili Pharmaceutical

GSK

Bayer

AbbVie

Taisho Pharmaceutical

Reckitt Benckiser

Perrigo

LEO Pharma

Ikeda Mohando

DermaPharm A/S

Bright Future Pharmaceutical

Dermatological Medicine Segment by Type

Calcineurin Inhibitors

Anti-acne

Anti-infectives

Corticosteroids

Retinoids

Others

Dermatological Medicine Segment by Application

Psoriasis

Alopecia

Atopic Dermatitis

Herpes

Rosacea

Others

Dermatological Medicine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dermatological Medicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Dermatological Medicine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dermatological Medicine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Dermatological Medicine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Dermatological Medicine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Dermatological Medicine sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Dermatological Medicine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Calcineurin Inhibitors Major Manufacturers Table 3. Anti-acne Major Manufacturers Table 4. Anti-infectives Major Manufacturers Table 5. Corticosteroids Major Manufacturers Table 6. Retinoids Major Manufacturers Table 7. Others Major Manufacturers Table 8. Global Dermatological Medicine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 9. Psoriasis Major Manufacturers Table 10. Alopecia Major Manufacturers Table 11. Atopic Dermatitis Major Manufacturers Table 12. Herpes Major Manufacturers Table 13. Rosacea Major Manufacturers Table 14. Others Major Manufacturers Table 15. Dermatological Medicine Industry Trends Table 16. Dermatological Medicine Industry Drivers Table 17. Dermatological Medicine Industry Opportunities and Challenges Table 18. Dermatological Medicine Industry Restraints Table 19. Global Dermatological Medicine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 20. Global Dermatological Medicine Revenue by Region (2021-2026) & (US$ Million) Table 21. Global Dermatological Medicine Revenue by Region (2027-2032) & (US$ Million) Table 22. Global Dermatological Medicine Revenue Market Share by Region (2021-2026) Table 23. Global Dermatological Medicine Revenue Market Share by Region (2027-2032) Table 24. Global Dermatological Medicine Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 25. Global Dermatological Medicine Sales by Region (2021-2026) & (K Units) Table 26. Global Dermatological Medicine Sales by Region (2027-2032) & (K Units) Table 27. Global Dermatological Medicine Sales Market Share by Region (2021-2026) Table 28. Global Dermatological Medicine Sales Market Share by Region (2027-2032) Table 29. Global Dermatological Medicine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 30. Global Dermatological Medicine Revenue Market Share by Manufacturers (2021-2026) Table 31. Global Dermatological Medicine Sales by Manufacturers (US$ Million) & (2021-2026) Table 32. Global Dermatological Medicine Sales Market Share by Manufacturers (2021-2026) Table 33. Global Dermatological Medicine Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 34. Global Dermatological Medicine Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 35. Global Dermatological Medicine Key Manufacturers Manufacturing Sites & Headquarters Table 36. Global Dermatological Medicine Manufacturers, Product Type & Application Table 37. Global Dermatological Medicine Manufacturers' Establishment Date Table 38. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 39. Global Dermatological Medicine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Dermatological Medicine Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Dermatological Medicine Revenue by Type (2021-2026) & (US$ Million) Table 42. Global Dermatological Medicine Revenue by Type (2027-2032) & (US$ Million) Table 43. Global Dermatological Medicine Revenue Market Share by Type (2021-2026) Table 44. Global Dermatological Medicine Revenue Market Share by Type (2027-2032) Table 45. Global Dermatological Medicine Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 46. Global Dermatological Medicine Sales by Type (2021-2026) & (K Units) Table 47. Global Dermatological Medicine Sales by Type (2027-2032) & (K Units) Table 48. Global Dermatological Medicine Sales Market Share by Type (2021-2026) Table 49. Global Dermatological Medicine Sales Market Share by Type (2027-2032) Table 50. Global Dermatological Medicine Price by Type (2021-2026) & (US$/Unit) Table 51. Global Dermatological Medicine Price by Type (2027-2032) & (US$/Unit) Table 52. Global Dermatological Medicine Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 53. Global Dermatological Medicine Revenue by Application (2021-2026) & (US$ Million) Table 54. Global Dermatological Medicine Revenue by Application (2027-2032) & (US$ Million) Table 55. Global Dermatological Medicine Revenue Market Share by Application (2021-2026) Table 56. Global Dermatological Medicine Revenue Market Share by Application (2027-2032) Table 57. Global Dermatological Medicine Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 58. Global Dermatological Medicine Sales by Application (2021-2026) & (K Units) Table 59. Global Dermatological Medicine Sales by Application (2027-2032) & (K Units) Table 60. Global Dermatological Medicine Sales Market Share by Application (2021-2026) Table 61. Global Dermatological Medicine Sales Market Share by Application (2027-2032) Table 62. Global Dermatological Medicine Price by Application (2021-2026) & (US$/Unit) Table 63. Global Dermatological Medicine Price by Application (2027-2032) & (US$/Unit) Table 64. Chongqing Huapont Pharm Co. Company Information Table 65. Chongqing Huapont Pharm Co. Business Overview Table 66. Chongqing Huapont Pharm Co. Dermatological Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Chongqing Huapont Pharm Co. Dermatological Medicine Product Portfolio Table 68. Chongqing Huapont Pharm Co. Recent Development Table 69. China National Pharmaceutical Group Company Information Table 70. China National Pharmaceutical Group Business Overview Table 71. China National Pharmaceutical Group Dermatological Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. China National Pharmaceutical Group Dermatological Medicine Product Portfolio Table 73. China National Pharmaceutical Group Recent Development Table 74. Xiuzheng Pharmaceutical Group Company Information Table 75. Xiuzheng Pharmaceutical Group Business Overview Table 76. Xiuzheng Pharmaceutical Group Dermatological Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Xiuzheng Pharmaceutical Group Dermatological Medicine Product Portfolio Table 78. Xiuzheng Pharmaceutical Group Recent Development Table 79. Johnson and Johnson Company Information Table 80. Johnson and Johnson Business Overview Table 81. Johnson and Johnson Dermatological Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Johnson and Johnson Dermatological Medicine Product Portfolio Table 83. Johnson and Johnson Recent Development Table 84. Merck Company Information Table 85. Merck Business Overview Table 86. Merck Dermatological Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Merck Dermatological Medicine Product Portfolio Table 88. Merck Recent Development Table 89. Harbin Letai Company Information Table 90. Harbin Letai Business Overview Table 91. Harbin Letai Dermatological Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Harbin Letai Dermatological Medicine Product Portfolio Table 93. Harbin Letai Recent Development Table 94. Pfizer Company Information Table 95. Pfizer Business Overview Table 96. Pfizer Dermatological Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Pfizer Dermatological Medicine Product Portfolio Table 98. Pfizer Recent Development Table 99. China Resources Pharmaceutical Group Company Information Table 100. China Resources Pharmaceutical Group Business Overview Table 101. China Resources Pharmaceutical Group Dermatological Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. China Resources Pharmaceutical Group Dermatological Medicine Product Portfolio Table 103. China Resources Pharmaceutical Group Recent Development Table 104. Hebei Xinglong Xili Pharmaceutical Company Information Table 105. Hebei Xinglong Xili Pharmaceutical Business Overview Table 106. Hebei Xinglong Xili Pharmaceutical Dermatological Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Hebei Xinglong Xili Pharmaceutical Dermatological Medicine Product Portfolio Table 108. Hebei Xinglong Xili Pharmaceutical Recent Development Table 109. GSK Company Information Table 110. GSK Business Overview Table 111. GSK Dermatological Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. GSK Dermatological Medicine Product Portfolio Table 113. GSK Recent Development Table 114. Bayer Company Information Table 115. Bayer Business Overview Table 116. Bayer Dermatological Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Bayer Dermatological Medicine Product Portfolio Table 118. Bayer Recent Development Table 119. AbbVie Company Information Table 120. AbbVie Business Overview Table 121. AbbVie Dermatological Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. AbbVie Dermatological Medicine Product Portfolio Table 123. AbbVie Recent Development Table 124. Taisho Pharmaceutical Company Information Table 125. Taisho Pharmaceutical Business Overview Table 126. Taisho Pharmaceutical Dermatological Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. Taisho Pharmaceutical Dermatological Medicine Product Portfolio Table 128. Taisho Pharmaceutical Recent Development Table 129. Reckitt Benckiser Company Information Table 130. Reckitt Benckiser Business Overview Table 131. Reckitt Benckiser Dermatological Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 132. Reckitt Benckiser Dermatological Medicine Product Portfolio Table 133. Reckitt Benckiser Recent Development Table 134. Perrigo Company Information Table 135. Perrigo Business Overview Table 136. Perrigo Dermatological Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 137. Perrigo Dermatological Medicine Product Portfolio Table 138. Perrigo Recent Development Table 139. LEO Pharma Company Information Table 140. LEO Pharma Business Overview Table 141. LEO Pharma Dermatological Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 142. LEO Pharma Dermatological Medicine Product Portfolio Table 143. LEO Pharma Recent Development Table 144. Ikeda Mohando Company Information Table 145. Ikeda Mohando Business Overview Table 146. Ikeda Mohando Dermatological Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 147. Ikeda Mohando Dermatological Medicine Product Portfolio Table 148. Ikeda Mohando Recent Development Table 149. DermaPharm A/S Company Information Table 150. DermaPharm A/S Business Overview Table 151. DermaPharm A/S Dermatological Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 152. DermaPharm A/S Dermatological Medicine Product Portfolio Table 153. DermaPharm A/S Recent Development Table 154. Bright Future Pharmaceutical Company Information Table 155. Bright Future Pharmaceutical Business Overview Table 156. Bright Future Pharmaceutical Dermatological Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 157. Bright Future Pharmaceutical Dermatological Medicine Product Portfolio Table 158. Bright Future Pharmaceutical Recent Development Table 159. North America Dermatological Medicine Revenue by Type (2021-2026) & (US$ Million) Table 160. North America Dermatological Medicine Revenue by Type (2027-2032) & (US$ Million) Table 161. North America Dermatological Medicine Sales by Type (2021-2026) & (K Units) Table 162. North America Dermatological Medicine Sales by Type (2027-2032) & (K Units) Table 163. North America Dermatological Medicine Sales Price by Type (2021-2026) & (US$/Unit) Table 164. North America Dermatological Medicine Sales Price by Type (2027-2032) & (US$/Unit) Table 165. North America Dermatological Medicine Revenue by Application (2021-2026) & (US$ Million) Table 166. North America Dermatological Medicine Revenue by Application (2027-2032) & (US$ Million) Table 167. North America Dermatological Medicine Sales by Application (2021-2026) & (K Units) Table 168. North America Dermatological Medicine Sales by Application (2027-2032) & (K Units) Table 169. North America Dermatological Medicine Sales Price by Application (2021-2026) & (US$/Unit) Table 170. North America Dermatological Medicine Sales Price by Application (2027-2032) & (US$/Unit) Table 171. North America Dermatological Medicine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 172. North America Dermatological Medicine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 173. North America Dermatological Medicine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 174. North America Dermatological Medicine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 175. North America Dermatological Medicine Sales by Country (2021-2026) & (K Units) Table 176. North America Dermatological Medicine Sales by Country (2027-2032) & (K Units) Table 177. North America Dermatological Medicine Sales Price by Country (2021-2026) & (US$/Unit) Table 178. North America Dermatological Medicine Sales Price by Country (2027-2032) & (US$/Unit) Table 179. United States Dermatological Medicine Revenue (2021-2032) & (US$ Million) Table 180. Canada Dermatological Medicine Revenue (2021-2032) & (US$ Million) Table 181. Europe Dermatological Medicine Revenue by Type (2021-2026) & (US$ Million) Table 182. Europe Dermatological Medicine Revenue by Type (2027-2032) & (US$ Million) Table 183. Europe Dermatological Medicine Sales by Type (2021-2026) & (K Units) Table 184. Europe Dermatological Medicine Sales by Type (2027-2032) & (K Units) Table 185. Europe Dermatological Medicine Sales Price by Type (2021-2026) & (US$/Unit) Table 186. Europe Dermatological Medicine Sales Price by Type (2027-2032) & (US$/Unit) Table 187. Europe Dermatological Medicine Revenue by Application (2021-2026) & (US$ Million) Table 188. Europe Dermatological Medicine Revenue by Application (2027-2032) & (US$ Million) Table 189. Europe Dermatological Medicine Sales by Application (2021-2026) & (K Units) Table 190. Europe Dermatological Medicine Sales by Application (2027-2032) & (K Units) Table 191. Europe Dermatological Medicine Sales Price by Application (2021-2026) & (US$/Unit) Table 192. Europe Dermatological Medicine Sales Price by Application (2027-2032) & (US$/Unit) Table 193. Europe Dermatological Medicine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 194. Europe Dermatological Medicine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 195. Europe Dermatological Medicine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 196. Europe Dermatological Medicine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 197. Europe Dermatological Medicine Sales by Country (2021-2026) & (K Units) Table 198. Europe Dermatological Medicine Sales by Country (2027-2032) & (K Units) Table 199. Europe Dermatological Medicine Sales Price by Country (2021-2026) & (US$/Unit) Table 200. Europe Dermatological Medicine Sales Price by Country (2027-2032) & (US$/Unit) Table 201. Germany Dermatological Medicine Revenue (2021-2032) & (US$ Million) Table 202. France Dermatological Medicine Revenue (2021-2032) & (US$ Million) Table 203. U.K. Dermatological Medicine Revenue (2021-2032) & (US$ Million) Table 204. Italy Dermatological Medicine Revenue (2021-2032) & (US$ Million) Table 205. Netherlands Dermatological Medicine Revenue (2021-2032) & (US$ Million) Table 206. China Dermatological Medicine Revenue by Type (2021-2026) & (US$ Million) Table 207. China Dermatological Medicine Revenue by Type (2027-2032) & (US$ Million) Table 208. China Dermatological Medicine Sales by Type (2021-2026) & (K Units) Table 209. China Dermatological Medicine Sales by Type (2027-2032) & (K Units) Table 210. China Dermatological Medicine Sales Price by Type (2021-2026) & (US$/Unit) Table 211. China Dermatological Medicine Sales Price by Type (2027-2032) & (US$/Unit) Table 212. China Dermatological Medicine Revenue by Application (2021-2026) & (US$ Million) Table 213. China Dermatological Medicine Revenue by Application (2027-2032) & (US$ Million) Table 214. China Dermatological Medicine Sales by Application (2021-2026) & (K Units) Table 215. China Dermatological Medicine Sales by Application (2027-2032) & (K Units) Table 216. China Dermatological Medicine Sales Price by Application (2021-2026) & (US$/Unit) Table 217. China Dermatological Medicine Sales Price by Application (2027-2032) & (US$/Unit) Table 218. Asia Dermatological Medicine Revenue by Type (2021-2026) & (US$ Million) Table 219. Asia Dermatological Medicine Revenue by Type (2027-2032) & (US$ Million) Table 220. Asia Dermatological Medicine Sales by Type (2021-2026) & (K Units) Table 221. Asia Dermatological Medicine Sales by Type (2027-2032) & (K Units) Table 222. Asia Dermatological Medicine Sales Price by Type (2021-2026) & (US$/Unit) Table 223. Asia Dermatological Medicine Sales Price by Type (2027-2032) & (US$/Unit) Table 224. Asia Dermatological Medicine Revenue by Application (2021-2026) & (US$ Million) Table 225. Asia Dermatological Medicine Revenue by Application (2027-2032) & (US$ Million) Table 226. Asia Dermatological Medicine Sales by Application (2021-2026) & (K Units) Table 227. Asia Dermatological Medicine Sales by Application (2027-2032) & (K Units) Table 228. Asia Dermatological Medicine Sales Price by Application (2021-2026) & (US$/Unit) Table 229. Asia Dermatological Medicine Sales Price by Application (2027-2032) & (US$/Unit) Table 230. Asia Dermatological Medicine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 231. Asia Dermatological Medicine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 232. Asia Dermatological Medicine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 233. Asia Dermatological Medicine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 234. Asia Dermatological Medicine Sales by Country (2021-2026) & (K Units) Table 235. Asia Dermatological Medicine Sales by Country (2027-2032) & (K Units) Table 236. Asia Dermatological Medicine Sales Price by Country (2021-2026) & (US$/Unit) Table 237. Asia Dermatological Medicine Sales Price by Country (2027-2032) & (US$/Unit) Table 238. Japan Dermatological Medicine Revenue (2021-2032) & (US$ Million) Table 239. South Korea Dermatological Medicine Revenue (2021-2032) & (US$ Million) Table 240. India Dermatological Medicine Revenue (2021-2032) & (US$ Million) Table 241. Australia Dermatological Medicine Revenue (2021-2032) & (US$ Million) Table 242. China Taiwan Dermatological Medicine Revenue (2021-2032) & (US$ Million) Table 243. Southeast Asia Dermatological Medicine Revenue (2021-2032) & (US$ Million) Table 244. SAMEA Dermatological Medicine Revenue by Type (2021-2026) & (US$ Million) Table 245. SAMEA Dermatological Medicine Revenue by Type (2027-2032) & (US$ Million) Table 246. SAMEA Dermatological Medicine Sales by Type (2021-2026) & (K Units) Table 247. SAMEA Dermatological Medicine Sales by Type (2027-2032) & (K Units) Table 248. SAMEA Dermatological Medicine Sales Price by Type (2021-2026) & (US$/Unit) Table 249. SAMEA Dermatological Medicine Sales Price by Type (2027-2032) & (US$/Unit) Table 250. SAMEA Dermatological Medicine Revenue by Application (2021-2026) & (US$ Million) Table 251. SAMEA Dermatological Medicine Revenue by Application (2027-2032) & (US$ Million) Table 252. SAMEA Dermatological Medicine Sales by Application (2021-2026) & (K Units) Table 253. SAMEA Dermatological Medicine Sales by Application (2027-2032) & (K Units) Table 254. SAMEA Dermatological Medicine Sales Price by Application (2021-2026) & (US$/Unit) Table 255. SAMEA Dermatological Medicine Sales Price by Application (2027-2032) & (US$/Unit) Table 256. SAMEA Dermatological Medicine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 257. SAMEA Dermatological Medicine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 258. SAMEA Dermatological Medicine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 259. SAMEA Dermatological Medicine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 260. SAMEA Dermatological Medicine Sales by Country (2021-2026) & (K Units) Table 261. SAMEA Dermatological Medicine Sales by Country (2027-2032) & (K Units) Table 262. SAMEA Dermatological Medicine Sales Price by Country (2021-2026) & (US$/Unit) Table 263. SAMEA Dermatological Medicine Sales Price by Country (2027-2032) & (US$/Unit) Table 264. Brazil Dermatological Medicine Revenue (2021-2032) & (US$ Million) Table 265. Argentina Dermatological Medicine Revenue (2021-2032) & (US$ Million) Table 266. Chile Dermatological Medicine Revenue (2021-2032) & (US$ Million) Table 267. Colombia Dermatological Medicine Revenue (2021-2032) & (US$ Million) Table 268. Peru Dermatological Medicine Revenue (2021-2032) & (US$ Million) Table 269. Saudi Arabia Dermatological Medicine Revenue (2021-2032) & (US$ Million) Table 270. Israel Dermatological Medicine Revenue (2021-2032) & (US$ Million) Table 271. UAE Dermatological Medicine Revenue (2021-2032) & (US$ Million) Table 272. Turkey Dermatological Medicine Revenue (2021-2032) & (US$ Million) Table 273. Iran Dermatological Medicine Revenue (2021-2032) & (US$ Million) Table 274. Egypt Dermatological Medicine Revenue (2021-2032) & (US$ Million) Table 275. Key Raw Materials Table 276. Raw Materials Key Suppliers Table 277. Dermatological Medicine Distributors List Table 278. Dermatological Medicine Customers List Table 279. Research Programs/Design for This Report Table 280. Authors List of This Report Table 281. Secondary Sources Table 282. Primary Sources List of Figures Figure 1. Dermatological Medicine Image Figure 2. Global Dermatological Medicine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Dermatological Medicine Market Size Share 2021 VS 2025 VS 2032 Figure 4. Calcineurin Inhibitors Image Figure 5. Anti-acne Image Figure 6. Anti-infectives Image Figure 7. Corticosteroids Image Figure 8. Retinoids Image Figure 9. Others Image Figure 10. Global Dermatological Medicine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Dermatological Medicine Market Size Share 2021 VS 2025 VS 2032 Figure 12. Psoriasis Image Figure 13. Alopecia Image Figure 14. Atopic Dermatitis Image Figure 15. Herpes Image Figure 16. Rosacea Image Figure 17. Others Image Figure 18. Global Dermatological Medicine Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 19. Global Dermatological Medicine Revenue (2021-2032) & (US$ Million) Figure 20. Global Dermatological Medicine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Dermatological Medicine Revenue Market Share by Region: 2025 Versus 2032 Figure 22. Global Dermatological Medicine Revenue Market Share by Region (2021-2032) Figure 23. Global Dermatological Medicine Sales (2021-2032) & (K Units) Figure 24. Global Dermatological Medicine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 25. Global Dermatological Medicine Sales Market Share by Region (2021-2032) Figure 26. US & Canada & Mexico Dermatological Medicine Sales YoY (2021-2032) & (K Units) Figure 27. Europe Dermatological Medicine Sales YoY (2021-2032) & (K Units) Figure 28. China Dermatological Medicine Sales YoY (2021-2032) & (K Units) Figure 29. Asia (Excluding China) Dermatological Medicine Sales YoY (2021-2032) & (K Units) Figure 30. South America, Middle East and Africa Dermatological Medicine Sales YoY (2021-2032) & (K Units) Figure 31. Global Dermatological Medicine Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 32. Global Dermatological Medicine Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 33. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 34. Global Dermatological Medicine Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Dermatological Medicine Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 36. Global Dermatological Medicine Revenue Market Share by Type (2021-2032) Figure 37. Global Dermatological Medicine Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 38. Global Dermatological Medicine Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 39. Global Dermatological Medicine Sales Market Share by Type (2021-2032) Figure 40. Global Dermatological Medicine Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 41. Global Dermatological Medicine Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 42. Global Dermatological Medicine Revenue Market Share by Application (2021-2032) Figure 43. Global Dermatological Medicine Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 44. Global Dermatological Medicine Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 45. Global Dermatological Medicine Sales Market Share by Application (2021-2032) Figure 46. North America Dermatological Medicine Revenue Share by Type (2021-2032) Figure 47. North America Dermatological Medicine Sales Share by Type (2021-2032) Figure 48. North America Dermatological Medicine Revenue Share by Application (2021-2032) Figure 49. North America Dermatological Medicine Sales Share by Application (2021-2032) Figure 50. North America Dermatological Medicine Revenue Share by Country (2021-2032) Figure 51. North America Dermatological Medicine Sales Share by Country (2021-2032) Figure 52. Europe Dermatological Medicine Revenue Share by Type (2021-2032) Figure 53. Europe Dermatological Medicine Sales Share by Type (2021-2032) Figure 54. Europe Dermatological Medicine Revenue Share by Application (2021-2032) Figure 55. Europe Dermatological Medicine Sales Share by Application (2021-2032) Figure 56. Europe Dermatological Medicine Revenue Share by Country (2021-2032) Figure 57. Europe Dermatological Medicine Sales Share by Country (2021-2032) Figure 58. China Dermatological Medicine Revenue Share by Type (2021-2032) Figure 59. China Dermatological Medicine Sales Share by Type (2021-2032) Figure 60. China Dermatological Medicine Revenue Share by Application (2021-2032) Figure 61. China Dermatological Medicine Sales Share by Application (2021-2032) Figure 62. Asia Dermatological Medicine Revenue Share by Type (2021-2032) Figure 63. Asia Dermatological Medicine Sales Share by Type (2021-2032) Figure 64. Asia Dermatological Medicine Revenue Share by Application (2021-2032) Figure 65. Asia Dermatological Medicine Sales Share by Application (2021-2032) Figure 66. Asia Dermatological Medicine Revenue Share by Country (2021-2032) Figure 67. Asia Dermatological Medicine Sales Share by Country (2021-2032) Figure 68. SAMEA Dermatological Medicine Revenue Share by Type (2021-2032) Figure 69. SAMEA Dermatological Medicine Sales Share by Type (2021-2032) Figure 70. SAMEA Dermatological Medicine Revenue Share by Application (2021-2032) Figure 71. SAMEA Dermatological Medicine Sales Share by Application (2021-2032) Figure 72. SAMEA Dermatological Medicine Revenue Share by Country (2021-2032) Figure 73. SAMEA Dermatological Medicine Sales Share by Country (2021-2032) Figure 74. Dermatological Medicine Value Chain Figure 75. Manufacturing Cost Structure Figure 76. Dermatological Medicine Production Mode & Process Figure 77. Direct Comparison with Distribution Share Figure 78. Distributors Profiles Figure 79. Years Considered Figure 80. Research Process Figure 81. Key Executives Interviewed

Scope & coverage.

Types
  • Calcineurin Inhibitors
  • Anti-acne
  • Anti-infectives
  • Corticosteroids
  • Retinoids
  • Others
Applications
  • Psoriasis
  • Alopecia
  • Atopic Dermatitis
  • Herpes
  • Rosacea
  • Others
Companies covered
  • Chongqing Huapont Pharm Co.
  • China National Pharmaceutical Group
  • Xiuzheng Pharmaceutical Group
  • Johnson and Johnson
  • Merck
  • Harbin Letai
  • Pfizer
  • China Resources Pharmaceutical Group
  • Hebei Xinglong Xili Pharmaceutical
  • GSK
  • Bayer
  • AbbVie
  • Taisho Pharmaceutical
  • Reckitt Benckiser
  • Perrigo
  • LEO Pharma
  • Ikeda Mohando
  • DermaPharm A/S
  • Bright Future Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Dermatological Medicine Market by Type
  3. 1.2.1 Global Dermatological Medicine Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Calcineurin Inhibitors
  5. 1.2.3 Anti-acne
  6. 1.2.4 Anti-infectives
  7. 1.2.5 Corticosteroids
  8. 1.2.6 Retinoids
  9. 1.2.7 Others
  10. 1.3 Dermatological Medicine Market by Application
  11. 1.3.1 Global Dermatological Medicine Market Size by Application, 2021 VS 2025 VS 2032
  12. 1.3.2 Psoriasis
  13. 1.3.3 Alopecia
  14. 1.3.4 Atopic Dermatitis
  15. 1.3.5 Herpes
  16. 1.3.6 Rosacea
  17. 1.3.7 Others
  18. 1.4 Assumptions and Limitations
  19. 1.5 Study Goals and Objectives
2 Dermatological Medicine Market Dynamics
  1. 2.1 Dermatological Medicine Industry Trends
  2. 2.2 Dermatological Medicine Industry Drivers
  3. 2.3 Dermatological Medicine Industry Opportunities and Challenges
  4. 2.4 Dermatological Medicine Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Dermatological Medicine Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Dermatological Medicine Revenue by Region
  3. 3.2.1 Global Dermatological Medicine Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Dermatological Medicine Revenue by Region (2021-2026)
  5. 3.2.3 Global Dermatological Medicine Revenue by Region (2027-2032)
  6. 3.2.4 Global Dermatological Medicine Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Dermatological Medicine Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Dermatological Medicine Sales by Region
  9. 3.4.1 Global Dermatological Medicine Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Dermatological Medicine Sales by Region (2021-2026)
  11. 3.4.3 Global Dermatological Medicine Sales by Region (2027-2032)
  12. 3.4.4 Global Dermatological Medicine Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Dermatological Medicine Revenue by Manufacturers
  2. 4.1.1 Global Dermatological Medicine Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Dermatological Medicine Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Dermatological Medicine Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Dermatological Medicine Sales by Manufacturers
  6. 4.2.1 Global Dermatological Medicine Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Dermatological Medicine Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Dermatological Medicine Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Dermatological Medicine Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Dermatological Medicine Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Dermatological Medicine Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Dermatological Medicine Manufacturers, Product Type & Application
  13. 4.7 Global Dermatological Medicine Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Dermatological Medicine Market CR5 and HHI
  16. 4.8.2 2025 Dermatological Medicine Tier 1, Tier 2, and Tier 3
5 Dermatological Medicine Market by Type
  1. 5.1 Global Dermatological Medicine Revenue by Type
  2. 5.1.1 Global Dermatological Medicine Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Dermatological Medicine Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Dermatological Medicine Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Dermatological Medicine Sales by Type
  6. 5.2.1 Global Dermatological Medicine Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Dermatological Medicine Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Dermatological Medicine Sales Market Share by Type (2021-2032)
  9. 5.3 Global Dermatological Medicine Price by Type
6 Dermatological Medicine Market by Application
  1. 6.1 Global Dermatological Medicine Revenue by Application
  2. 6.1.1 Global Dermatological Medicine Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Dermatological Medicine Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Dermatological Medicine Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Dermatological Medicine Sales by Application
  6. 6.2.1 Global Dermatological Medicine Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Dermatological Medicine Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Dermatological Medicine Sales Market Share by Application (2021-2032)
  9. 6.3 Global Dermatological Medicine Price by Application
7 Company Profiles
  1. 7.1 Chongqing Huapont Pharm Co.
  2. 7.1.1 Chongqing Huapont Pharm Co. Company Information
  3. 7.1.2 Chongqing Huapont Pharm Co. Business Overview
  4. 7.1.3 Chongqing Huapont Pharm Co. Dermatological Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Chongqing Huapont Pharm Co. Dermatological Medicine Product Portfolio
  6. 7.1.5 Chongqing Huapont Pharm Co. Recent Developments
  7. 7.2 China National Pharmaceutical Group
  8. 7.2.1 China National Pharmaceutical Group Company Information
  9. 7.2.2 China National Pharmaceutical Group Business Overview
  10. 7.2.3 China National Pharmaceutical Group Dermatological Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 China National Pharmaceutical Group Dermatological Medicine Product Portfolio
  12. 7.2.5 China National Pharmaceutical Group Recent Developments
  13. 7.3 Xiuzheng Pharmaceutical Group
  14. 7.3.1 Xiuzheng Pharmaceutical Group Company Information
  15. 7.3.2 Xiuzheng Pharmaceutical Group Business Overview
  16. 7.3.3 Xiuzheng Pharmaceutical Group Dermatological Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Xiuzheng Pharmaceutical Group Dermatological Medicine Product Portfolio
  18. 7.3.5 Xiuzheng Pharmaceutical Group Recent Developments
  19. 7.4 Johnson and Johnson
  20. 7.4.1 Johnson and Johnson Company Information
  21. 7.4.2 Johnson and Johnson Business Overview
  22. 7.4.3 Johnson and Johnson Dermatological Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Johnson and Johnson Dermatological Medicine Product Portfolio
  24. 7.4.5 Johnson and Johnson Recent Developments
  25. 7.5 Merck
  26. 7.5.1 Merck Company Information
  27. 7.5.2 Merck Business Overview
  28. 7.5.3 Merck Dermatological Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Merck Dermatological Medicine Product Portfolio
  30. 7.5.5 Merck Recent Developments
  31. 7.6 Harbin Letai
  32. 7.6.1 Harbin Letai Company Information
  33. 7.6.2 Harbin Letai Business Overview
  34. 7.6.3 Harbin Letai Dermatological Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Harbin Letai Dermatological Medicine Product Portfolio
  36. 7.6.5 Harbin Letai Recent Developments
  37. 7.7 Pfizer
  38. 7.7.1 Pfizer Company Information
  39. 7.7.2 Pfizer Business Overview
  40. 7.7.3 Pfizer Dermatological Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Pfizer Dermatological Medicine Product Portfolio
  42. 7.7.5 Pfizer Recent Developments
  43. 7.8 China Resources Pharmaceutical Group
  44. 7.8.1 China Resources Pharmaceutical Group Company Information
  45. 7.8.2 China Resources Pharmaceutical Group Business Overview
  46. 7.8.3 China Resources Pharmaceutical Group Dermatological Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 China Resources Pharmaceutical Group Dermatological Medicine Product Portfolio
  48. 7.8.5 China Resources Pharmaceutical Group Recent Developments
  49. 7.9 Hebei Xinglong Xili Pharmaceutical
  50. 7.9.1 Hebei Xinglong Xili Pharmaceutical Company Information
  51. 7.9.2 Hebei Xinglong Xili Pharmaceutical Business Overview
  52. 7.9.3 Hebei Xinglong Xili Pharmaceutical Dermatological Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Hebei Xinglong Xili Pharmaceutical Dermatological Medicine Product Portfolio
  54. 7.9.5 Hebei Xinglong Xili Pharmaceutical Recent Developments
  55. 7.10 GSK
  56. 7.10.1 GSK Company Information
  57. 7.10.2 GSK Business Overview
  58. 7.10.3 GSK Dermatological Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 GSK Dermatological Medicine Product Portfolio
  60. 7.10.5 GSK Recent Developments
  61. 7.11 Bayer
  62. 7.11.1 Bayer Company Information
  63. 7.11.2 Bayer Business Overview
  64. 7.11.3 Bayer Dermatological Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Bayer Dermatological Medicine Product Portfolio
  66. 7.11.5 Bayer Recent Developments
  67. 7.12 AbbVie
  68. 7.12.1 AbbVie Company Information
  69. 7.12.2 AbbVie Business Overview
  70. 7.12.3 AbbVie Dermatological Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 AbbVie Dermatological Medicine Product Portfolio
  72. 7.12.5 AbbVie Recent Developments
  73. 7.13 Taisho Pharmaceutical
  74. 7.13.1 Taisho Pharmaceutical Company Information
  75. 7.13.2 Taisho Pharmaceutical Business Overview
  76. 7.13.3 Taisho Pharmaceutical Dermatological Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Taisho Pharmaceutical Dermatological Medicine Product Portfolio
  78. 7.13.5 Taisho Pharmaceutical Recent Developments
  79. 7.14 Reckitt Benckiser
  80. 7.14.1 Reckitt Benckiser Company Information
  81. 7.14.2 Reckitt Benckiser Business Overview
  82. 7.14.3 Reckitt Benckiser Dermatological Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Reckitt Benckiser Dermatological Medicine Product Portfolio
  84. 7.14.5 Reckitt Benckiser Recent Developments
  85. 7.15 Perrigo
  86. 7.15.1 Perrigo Company Information
  87. 7.15.2 Perrigo Business Overview
  88. 7.15.3 Perrigo Dermatological Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Perrigo Dermatological Medicine Product Portfolio
  90. 7.15.5 Perrigo Recent Developments
  91. 7.16 LEO Pharma
  92. 7.16.1 LEO Pharma Company Information
  93. 7.16.2 LEO Pharma Business Overview
  94. 7.16.3 LEO Pharma Dermatological Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 LEO Pharma Dermatological Medicine Product Portfolio
  96. 7.16.5 LEO Pharma Recent Developments
  97. 7.17 Ikeda Mohando
  98. 7.17.1 Ikeda Mohando Company Information
  99. 7.17.2 Ikeda Mohando Business Overview
  100. 7.17.3 Ikeda Mohando Dermatological Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Ikeda Mohando Dermatological Medicine Product Portfolio
  102. 7.17.5 Ikeda Mohando Recent Developments
  103. 7.18 DermaPharm A/S
  104. 7.18.1 DermaPharm A/S Company Information
  105. 7.18.2 DermaPharm A/S Business Overview
  106. 7.18.3 DermaPharm A/S Dermatological Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 DermaPharm A/S Dermatological Medicine Product Portfolio
  108. 7.18.5 DermaPharm A/S Recent Developments
  109. 7.19 Bright Future Pharmaceutical
  110. 7.19.1 Bright Future Pharmaceutical Company Information
  111. 7.19.2 Bright Future Pharmaceutical Business Overview
  112. 7.19.3 Bright Future Pharmaceutical Dermatological Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
  113. 7.19.4 Bright Future Pharmaceutical Dermatological Medicine Product Portfolio
  114. 7.19.5 Bright Future Pharmaceutical Recent Developments
8 North America
  1. 8.1 North America Dermatological Medicine Market Size by Type
  2. 8.1.1 North America Dermatological Medicine Revenue by Type (2021-2032)
  3. 8.1.2 North America Dermatological Medicine Sales by Type (2021-2032)
  4. 8.1.3 North America Dermatological Medicine Price by Type (2021-2032)
  5. 8.2 North America Dermatological Medicine Market Size by Application
  6. 8.2.1 North America Dermatological Medicine Revenue by Application (2021-2032)
  7. 8.2.2 North America Dermatological Medicine Sales by Application (2021-2032)
  8. 8.2.3 North America Dermatological Medicine Price by Application (2021-2032)
  9. 8.3 North America Dermatological Medicine Market Size by Country
  10. 8.3.1 North America Dermatological Medicine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Dermatological Medicine Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Dermatological Medicine Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Dermatological Medicine Market Size by Type
  2. 9.1.1 Europe Dermatological Medicine Revenue by Type (2021-2032)
  3. 9.1.2 Europe Dermatological Medicine Sales by Type (2021-2032)
  4. 9.1.3 Europe Dermatological Medicine Price by Type (2021-2032)
  5. 9.2 Europe Dermatological Medicine Market Size by Application
  6. 9.2.1 Europe Dermatological Medicine Revenue by Application (2021-2032)
  7. 9.2.2 Europe Dermatological Medicine Sales by Application (2021-2032)
  8. 9.2.3 Europe Dermatological Medicine Price by Application (2021-2032)
  9. 9.3 Europe Dermatological Medicine Market Size by Country
  10. 9.3.1 Europe Dermatological Medicine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Dermatological Medicine Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Dermatological Medicine Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Dermatological Medicine Market Size by Type
  2. 10.1.1 China Dermatological Medicine Revenue by Type (2021-2032)
  3. 10.1.2 China Dermatological Medicine Sales by Type (2021-2032)
  4. 10.1.3 China Dermatological Medicine Price by Type (2021-2032)
  5. 10.2 China Dermatological Medicine Market Size by Application
  6. 10.2.1 China Dermatological Medicine Revenue by Application (2021-2032)
  7. 10.2.2 China Dermatological Medicine Sales by Application (2021-2032)
  8. 10.2.3 China Dermatological Medicine Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Dermatological Medicine Market Size by Type
  2. 11.1.1 Asia Dermatological Medicine Revenue by Type (2021-2032)
  3. 11.1.2 Asia Dermatological Medicine Sales by Type (2021-2032)
  4. 11.1.3 Asia Dermatological Medicine Price by Type (2021-2032)
  5. 11.2 Asia Dermatological Medicine Market Size by Application
  6. 11.2.1 Asia Dermatological Medicine Revenue by Application (2021-2032)
  7. 11.2.2 Asia Dermatological Medicine Sales by Application (2021-2032)
  8. 11.2.3 Asia Dermatological Medicine Price by Application (2021-2032)
  9. 11.3 Asia Dermatological Medicine Market Size by Country
  10. 11.3.1 Asia Dermatological Medicine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Dermatological Medicine Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Dermatological Medicine Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Dermatological Medicine Market Size by Type
  2. 12.1.1 SAMEA Dermatological Medicine Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Dermatological Medicine Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Dermatological Medicine Price by Type (2021-2032)
  5. 12.2 SAMEA Dermatological Medicine Market Size by Application
  6. 12.2.1 SAMEA Dermatological Medicine Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Dermatological Medicine Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Dermatological Medicine Price by Application (2021-2032)
  9. 12.3 SAMEA Dermatological Medicine Market Size by Country
  10. 12.3.1 SAMEA Dermatological Medicine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Dermatological Medicine Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Dermatological Medicine Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Dermatological Medicine Value Chain Analysis
  2. 13.1.1 Dermatological Medicine Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Dermatological Medicine Production Mode & Process
  6. 13.2 Dermatological Medicine Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Dermatological Medicine Distributors
  9. 13.2.3 Dermatological Medicine Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst